Novo Nordisk Profit Margin 2006-2019 | NVO
Current and historical gross margin, operating margin and net profit margin for Novo Nordisk (NVO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Novo Nordisk net profit margin as of June 30, 2019 is 32.16%.
|Novo Nordisk Annual Profit Margins
|Novo Nordisk Quarterly Profit Margins
||Large Cap Pharmaceutical
Novo Nordisk is a world leader in insulin and diabetes care and also manufactures and markets a variety of other pharmaceutical products. Furthermore the company is the world's largest producer of industrial enzyme products. The company believes that everyone must care for the environment and our natural resources.